Brief: Pharnext Identifies Frequently Prescribed Drugs To Be Repurposed For Fighting Covid-19
23/03/2020 06:42
March 23 (Reuters) - PHARNEXT SA PHARN.PA :
* PHARNEXT ANNOUNCES IDENTIFICATION OF A LARGE SET OF
FREQUENTLY
PRESCRIBED DRUGS TO BE REPURPOSED FOR FIGHTING COVID-19, USING
ITS PLEOTHERAPY PLATFORM
* ON CORONAVIRUS: A NOVEL STRATEGY TO RAPIDLY REPOSITION
DRUGS
USING EXISTING COVID-19 CLINICAL DATA
Source text for Eikon: ID:nEQ2vSdWja
Further company coverage: PHARN.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587785110;))
Recent news on Pharnext SCA
See all newsBrief: Pharnext Progresses On Charcot-Marie-Tooth Disease Study
Brief: Pharnext Reports Topline Results From Pivotal Phase III Clinical Trial Of PXT3003 In Charcot-Marie-Tooth Disease Type 1A
Brief: Pharnext Receives Offer Valuing Its Drug Candidate For Charcotmarie-Tooth Disease At Over Eur 500 Mln
Brief: Pharnext Appoints Dr Gilbert Wagener As Chief Medical Officer
Brief: Pharnext Reports Significant Progress In Search For Pharmaceutical Partners To Finance Its Development